Related Experiment Videos
Adiaspiromycosis treated successfully with ketoconazole
L C Severo1, G R Geyer, J J Camargo
1Servico de Micologia, Instituto de Pesquisas Biologicas, SSMA, Porto Alegre, Brazil.
Summary
This report details the first case of adiaspiromycosis with diffuse lung involvement in a severely ill patient. Successful treatment with antifungal chemotherapy highlights a new therapeutic approach for this rare fungal infection.
Area of Science:
- Mycology
- Pulmonology
- Infectious Diseases
Background:
- Adiaspiromycosis is a rare fungal infection caused by Emmonsia crescens, typically affecting the respiratory tract of small mammals.
- Human infections are uncommon and usually present with localized granulomatous lesions.
Observation:
- A 37-year-old Caucasian male presented with severe illness due to diffuse bilateral pulmonary involvement.
- The patient's clinical presentation indicated extensive fungal infiltration of both lungs.
Findings:
- This case represents the first documented instance of adiaspiromycosis manifesting with widespread disease affecting both lungs.
- Successful management was achieved using a course of antifungal chemotherapy, demonstrating treatment efficacy.
Implications:
- This case expands the understanding of adiaspiromycosis's clinical spectrum, particularly its potential for severe, diffuse pulmonary manifestation in humans.
- The successful treatment outcome suggests that antifungal chemotherapy can be an effective strategy for managing severe cases of adiaspiromycosis.
- Further research into the pathogenesis and optimal treatment of human adiaspiromycosis is warranted.